The three ways people currently access retatrutide: Clinical trials: Free pharmaceutical-grade retatrutide with full medical supervision (but you might get placebo) Compounding pharmacies: Legal with a prescription, quality varies, costs $200-500/month Research peptides: Grey market, sold as "not for human consumption," costs $150-500/month, no quality guarantees See our complete guide to getting retatrutide for details on each option
Do not attempt to continue use or reduce the dose
Delivery was fast and reliable
The timeline: what to expect and when Based on practitioner reports and the available clinical data, here is what the general timeline looks like for GLP-1 microdosing in autoimmune conditions
Age, sex, and metabolic health status also play roles, with some evidence suggesting that younger patients and those without significant metabolic comorbidities may respond more rapidly
The FDA label for Increlex explicitly warns of hypoglycaemia, intracranial hypertension, and slipped capital femoral epiphysis as serious adverse events